Trial · NCT04540887
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pelvic Pain, as Measured by the Numeric Rating Scale (NRS) | Pulsed Electromagnetic Field Therapy (PEMF) | 6.70 | Standard Deviation 0.675 | score on a scale | |
| Change From Baseline Pelvic Pain, as Measured by the Numeric Rating Scale (NRS) | Pulsed Electromagnetic Field Therapy (PEMF) | 4.18 | Standard Deviation 1.462 | score on a scale | |
| Change From Baseline Pelvic Pain, as Measured by the Numeric Rating Scale (NRS) | Pulsed Electromagnetic Field Therapy (PEMF) | 5.34 | Standard Deviation 1.845 | score on a scale | |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Problem Index (ICPI) | Pulsed Electromagnetic Field Therapy (PEMF) | Baseline | 13 | Standard Deviation 1.927 | scores on a scale |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Problem Index (ICPI) | Pulsed Electromagnetic Field Therapy (PEMF) | Week 4 | 9.125 | Standard Deviation 4.581 | scores on a scale |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Problem Index (ICPI) | Pulsed Electromagnetic Field Therapy (PEMF) | Week 12 | 10.75 | Standard Deviation 3.742 | scores on a scale |
| Change in IC/BPS Symptoms, as Measured by Wake Forest Baptist Health IC/BPS Global Response Assessment (GRA) | Treatment | Baseline | 0 | Inter-Quartile Range 0 to 0 | score on a scale |
| Change in IC/BPS Symptoms, as Measured by Wake Forest Baptist Health IC/BPS Global Response Assessment (GRA) | Treatment | 4-weeks post-treatment | 2 | Inter-Quartile Range 1 to 2 | score on a scale |
| Change in IC/BPS Symptoms, as Measured by Wake Forest Baptist Health IC/BPS Global Response Assessment (GRA) | Treatment | 8-weeks post-treatment | 2 | Inter-Quartile Range 1 to 3 | score on a scale |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) | Treatment | Baseline before beginning treatment | 13.875 | Standard Deviation 2.949 | scores on a scale |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) | Treatment | Week 4 | 9 | Standard Deviation 4.781 | scores on a scale |
| Change in IC/BPS Symptoms, as Measured by O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) | Treatment | Week 12 | 10 | Standard Deviation 3.741 | scores on a scale |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Total Urine Volume (TUV in mL) (Baseline) | 2808.68 | Standard Deviation 1498.93 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Total Urine Volume (TUV in mL) (Week 4) | 2511.67 | Standard Deviation 1514.67 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Maximum Voided Volume (MVV in mL) (Baseline) | 406.71 | Standard Deviation 234.13 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Maximum Voided Volume (MVV in mL) (Week 4) | 454.29 | Standard Deviation 307.60 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Mean Voided Volume (mL) (Baseline) | 215.45 | Standard Deviation 116.38 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Mean Voided Volume (mL) (Week 4) | 229.67 | Standard Deviation 140.63 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Fluid Intake (Baseline) | 1701.52 | Standard Deviation 600.00 | mL |
| Change in IC/BPS Symptoms, as Recorded in Patient Voiding Diary - Void and Intake Measurements | Treatment | Fluid Intake (Week 4) | 1594.69 | Standard Deviation 668.17 | mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04540887/results